Drug Pricing Regulations
-
{
- All
- News
-
Historic India-EU Trade Deal Could Impact Prices Of Weight Loss And Lifesaving Drugs, Here's How
India's landmark free trade deal with the European Union may lower import costs for some medicines, including weight-loss and lifesaving drugs. But experts say patient prices will depend on patents, regulation, and how benefits pass through the suppl
-
New Study Highlights Drug Pricing And Regulation Issues In India
A new government study exposes serious flaws in India's drug pricing and regulation infrastructure. This study reveals how systemic failures impact drug pricing.
-
On Sputnik V For India, Price Issues - AstraZeneca Price Too Low, Says Maker
Despite India's drug regulator DCGI (Drugs Controller General of India) clearing the Russian Sputnik V vaccine for use in the country, there is still no decision on the price at which the vaccine will be procured by the government. Price negotiations
-
All You Need To Know About Sputnik V, India's Third Covid Vaccine
Russia's Sputnik V has been cleared by India's drug regulator making it the third vaccine to be the approved for emergency use in the country against the deadly coronavirus.
-
No Dual MRPs From Next Year. Cinemas, Malls, Airports Can't Charge More
Union Food and Consumer Affairs Minister Ram Vilas Paswan has approved amendments to the Legal Metrology (Packaged Commodities) Rules, 2011, that will come into effect from January 1, 2018.
-
Cancer, Diabetes and HIV Drugs To Become Cheaper Post GST
Country's drug price regulator, NPPA has stepped in and released a notification on keeping the cost of key medicines affordable by revising prices of 761 drugs.
-
Price Cap On Stents Hailed By All, But Serious Concerns Remain
The drug pricing regulator has directed that in cases of evidence of artificial stent shortage, the state governments can proceed against the manufacturers and seize their stent stocks as per the provisions of the Drug Price Control Order, 2013.
-
Price Cap On Stents Hailed By All, But Serious Concerns Remain
The drug pricing regulator has directed that in cases of evidence of artificial stent shortage, the state governments can proceed against the manufacturers and seize their stent stocks as per the provisions of the Drug Price Control Order, 2013.
-
Government To Amend Norms In 15 Days For Fixing Prices Of 350 Drugs
Drugs Prices Control Order will be amended in the next 15 days to enable the regulator NPPA to fix prices of about 350 medicines whose market data is not available, Union Minister Ananth Kumar said today.
-
India Caps Prices of 108 More Medicines; Drugmakers to Take Hit
India's pharmaceutical pricing regulator has cut and capped the prices of more than 100 drugs used to treat diseases ranging from diabetes to HIV to malaria, a move likely to hit the profit margins of drug firms like Sanofi SA, Abbott Laboratories and Ranbaxy Laboratories Ltd.
-
Historic India-EU Trade Deal Could Impact Prices Of Weight Loss And Lifesaving Drugs, Here's How
India's landmark free trade deal with the European Union may lower import costs for some medicines, including weight-loss and lifesaving drugs. But experts say patient prices will depend on patents, regulation, and how benefits pass through the suppl
-
New Study Highlights Drug Pricing And Regulation Issues In India
A new government study exposes serious flaws in India's drug pricing and regulation infrastructure. This study reveals how systemic failures impact drug pricing.
-
On Sputnik V For India, Price Issues - AstraZeneca Price Too Low, Says Maker
Despite India's drug regulator DCGI (Drugs Controller General of India) clearing the Russian Sputnik V vaccine for use in the country, there is still no decision on the price at which the vaccine will be procured by the government. Price negotiations
-
All You Need To Know About Sputnik V, India's Third Covid Vaccine
Russia's Sputnik V has been cleared by India's drug regulator making it the third vaccine to be the approved for emergency use in the country against the deadly coronavirus.
-
No Dual MRPs From Next Year. Cinemas, Malls, Airports Can't Charge More
Union Food and Consumer Affairs Minister Ram Vilas Paswan has approved amendments to the Legal Metrology (Packaged Commodities) Rules, 2011, that will come into effect from January 1, 2018.
-
Cancer, Diabetes and HIV Drugs To Become Cheaper Post GST
Country's drug price regulator, NPPA has stepped in and released a notification on keeping the cost of key medicines affordable by revising prices of 761 drugs.
-
Price Cap On Stents Hailed By All, But Serious Concerns Remain
The drug pricing regulator has directed that in cases of evidence of artificial stent shortage, the state governments can proceed against the manufacturers and seize their stent stocks as per the provisions of the Drug Price Control Order, 2013.
-
Price Cap On Stents Hailed By All, But Serious Concerns Remain
The drug pricing regulator has directed that in cases of evidence of artificial stent shortage, the state governments can proceed against the manufacturers and seize their stent stocks as per the provisions of the Drug Price Control Order, 2013.
-
Government To Amend Norms In 15 Days For Fixing Prices Of 350 Drugs
Drugs Prices Control Order will be amended in the next 15 days to enable the regulator NPPA to fix prices of about 350 medicines whose market data is not available, Union Minister Ananth Kumar said today.
-
India Caps Prices of 108 More Medicines; Drugmakers to Take Hit
India's pharmaceutical pricing regulator has cut and capped the prices of more than 100 drugs used to treat diseases ranging from diabetes to HIV to malaria, a move likely to hit the profit margins of drug firms like Sanofi SA, Abbott Laboratories and Ranbaxy Laboratories Ltd.
